Cargando…

Prostate‐specific antigen testing among young men: an opportunity to improve value

INTRODUCTION: Prostate cancer screening using prostate‐specific antigen (PSA) testing remains widespread. The prevalence of PSA testing in young men is unknown and may be an appropriate target for improving health care by decreasing low‐value testing in this age group. The purpose of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lange, Suzanne M., Ambrose, Jacob P., Flynn, Michael C., Lowrance, William T., Hanson, Heidi A., O’Neil, Brock B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957163/ https://www.ncbi.nlm.nih.gov/pubmed/33626214 http://dx.doi.org/10.1002/cam4.3800

Ejemplares similares

Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score
por: Herget, Kimberly A., et al.
Publicado: (2015)

Prostate cancer incidence in men with prostate‐specific antigen below 3 ng/mL: The Finnish Randomized Study of Screening for Prostate Cancer
por: Ola, Idris Olasunmbo, et al.
Publicado: (2022)

Prostate Cancer, Prostate Cancer Death, and Death from Other Causes, Among Men with Metabolic Aberrations
por: Häggström, Christel, et al.
Publicado: (2014)

Are Men Making Informed Decisions According to the Prostate-Specific Antigen Test Guidelines? Analysis of the 2015 Behavioral Risk Factor Surveillance System
por: Cooper, Dexter L., et al.
Publicado: (2019)

Demographics, stage distribution, and relative roles of surgery and radiotherapy on survival of persons with primary prostate sarcomas
por: Tward, Jonathan D., et al.
Publicado: (2018)

Which Prostate Cancers are Undetected by Multiparametric Magnetic Resonance Imaging in Men with Previous Prostate Biopsy? An Analysis from the PICTURE Study
por: Norris, Joseph M., et al.
Publicado: (2021)

Financial toxicity and strain among men receiving prostate cancer care in an equal access healthcare system
por: Bauer, Alexandria G., et al.
Publicado: (2020)

Prognostic value of miR-21 for prostate cancer: a systematic review and meta-analysis
por: Stafford, M.Y. Cynthia, et al.
Publicado: (2022)

Overexpression of claspin promotes docetaxel resistance and is associated with prostate‐specific antigen recurrence in prostate cancer
por: Babasaki, Takashi, et al.
Publicado: (2021)

The Value of Phenotypic Precision Medicine in Prostate Cancer
por: Hawkey, Nathan M, et al.
Publicado: (2022)

Identifying Prostate Cancer Among Men with Lower Urinary Tract Symptoms
por: Nordström, Tobias, et al.
Publicado: (2021)

Barriers to obtaining prostate multi‐parametric magnetic resonance imaging in African‐American men on active surveillance for prostate cancer
por: Walton, Eric L., et al.
Publicado: (2019)

Five-Year Prospective Observational Study of African-American Men on Active Surveillance for Prostate Cancer Demonstrates Race Is Not Predictive of Oncologic Outcomes
por: Pincus, Joshua, et al.
Publicado: (2022)

Defining Prostatic Vascular Pedicle Recurrence and the Anatomy of Local Recurrence of Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography
por: Dundee, Philip, et al.
Publicado: (2022)

BMI trajectories and risk of overall and grade‐specific prostate cancer: An observational cohort study among men seen for prostatic conditions
por: Wang, Kai, et al.
Publicado: (2018)

Metformin reduces prostate cancer risk among men with benign prostatic hyperplasia: A nationwide population‐based cohort study
por: Kuo, Yu‐Jui, et al.
Publicado: (2019)

Long‐term health‐related quality of life among men with prostate cancer in the Finnish randomized study of screening for prostate cancer
por: Talala, Kirsi, et al.
Publicado: (2020)

The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer
por: Castro, Elena, et al.
Publicado: (2016)

Prostate-Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate Cancer
por: Sheehan, Beshara, et al.
Publicado: (2022)

The contemporary role of renal mass biopsy in the management of small renal tumors
por: Lim, Amy, et al.
Publicado: (2012)

The STHLM3-model, Risk-based Prostate Cancer Testing Identifies Men at High Risk Without Inducing Negative Psychosocial Effects
por: Koitsalu, Marie, et al.
Publicado: (2021)

Multifunctionality of prostatic acid phosphatase in prostate cancer pathogenesis
por: Alpert, Evgenia, et al.
Publicado: (2021)

Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer
por: Crawley, Danielle, et al.
Publicado: (2016)

Socioeconomic status and diagnosis, treatment, and mortality in men with prostate cancer. Nationwide population‐based study
por: Tomic, Katarina, et al.
Publicado: (2018)

Predictors of adherence to a 12‐week exercise program among men treated for prostate cancer: ENGAGE study
por: Craike, Melinda, et al.
Publicado: (2016)

Assessment on clinical value of prostate health index in the diagnosis of prostate cancer
por: Zhang, Guangying, et al.
Publicado: (2019)

Clinical Application of the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation Score for Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer
por: Aerts, Jan, et al.
Publicado: (2023)

Circulating insulin‐like growth factor‐I, total and free testosterone concentrations and prostate cancer risk in 200 000 men in UK Biobank
por: Watts, Eleanor L., et al.
Publicado: (2020)

Values and preferences of men for undergoing prostate-specific antigen screening for prostate cancer: a systematic review
por: Vernooij, Robin W M, et al.
Publicado: (2018)

Association between PSA values and surveillance quality after prostate cancer surgery
por: Chapman, Christina Hunter, et al.
Publicado: (2019)

Clinical Value of a Routine Urine Culture Prior to Transrectal Prostate Biopsy
por: Örtegren, Joakim, et al.
Publicado: (2022)

Association of Urinary MyProstateScore, Age, and Prostate Volume in a Longitudinal Cohort of Healthy Men: Long-term Findings from the Olmsted County Study
por: Tosoian, Jeffrey J., et al.
Publicado: (2021)

Changes in Characteristics of Men with Lethal Prostate Cancer During the Past 25 Years: Description of Population-based Deaths
por: Lycken, Magdalena, et al.
Publicado: (2022)

Pembrolizumab in men with heavily treated metastatic castrate‐resistant prostate cancer
por: Tucker, Matthew D., et al.
Publicado: (2019)

A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate Biopsy
por: Kelly, Brian D., et al.
Publicado: (2023)

TGM4: an immunogenic prostate-restricted antigen
por: Lopez-Bujanda, Zoila A, et al.
Publicado: (2021)

Antibody-Based Therapeutics for the Treatment of Renal Cell Carcinoma: Challenges and Opportunities
por: Mahmoud, Ahmed M, et al.
Publicado: (2023)

Investigating the effects of lycopene and green tea on the metabolome of men at risk of prostate cancer: The ProDiet randomised controlled trial
por: Beynon, Rhona A., et al.
Publicado: (2018)

Evaluating palliative opportunities in pediatric patients with leukemia and lymphoma
por: Labudde, Emily J., et al.
Publicado: (2021)

Opportunities for strengthening provider-initiated testing and counselling for HIV in Namibia
por: Davyduke, Tracy, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_j8cjlqcarambbjiea2310qj6gc